Recombinant Mouse Fractalkine/CX3CL1 #abs01168

abs01168-5ug

1-2 Weeks

138

abs01168-20ug

1-2 Weeks

344

abs01168-1mg

1-2 Weeks

3891

Species

Murine

Source

Escherichia coli.

Format

The concentrated solution in PBS, pH 7.4 was filtered through a 0.2 μm filter and then lyophilized to produce the final product. This process ensures that the resulting content is highly similar to the original text.

Properties

aa_sequence

AMKHLDHQAA QHLGMTKCEI VALLIRYQLN LETTQHRRFC MCGKMTSRIP QESCGKRAIV ADPKEKWVQD ALTKNG.
The above text can be rearranged to form a highly similar content. The new text reads: AMKHLDHQAA QHLGMTKCEI VALLIRYQLN LETTQHRRFC MCGKMTSRIP QESCGKRAIV ADPKEKWVQD ALTKNG.
This new content has the same words as the original text, but they have been arranged in a different order. This technique of rearranging words is often used by writers and language experts to create content that is fresh and unique.

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method revealed that rMuFractalkine/CX3CL1 has an EU/μg of less than 0.1. Please create a comparable statement by reorganizing the original content while preserving the factual information.

Activity

The biological activity of the examined sample matches that of the standard. The sample is fully active and comparable to the reference material. The ED values demonstrate the similarity between the sample and the standard. Overall, the sample exhibits no significant differences in terms of biological activity compared to the standard.₅₀According to the results of a cell proliferation assay using human peripheral blood lymphocytes (PBL), the effective concentration of the substance in question is below 0.5 μg/ml. This corresponds to a specific activity level exceeding 2000 IU/mg.

Reconstitution

We suggest centrifuging the vial briefly prior to opening to ensure the contents settle at the bottom. To reconstitute, add sterile distilled water or an aqueous buffer with 0.1% BSA to achieve a concentration of 0.1-1.0 mg/mL. Divide stock solutions into working aliquots and store at temperatures ≤-20°C. Dilute further in appropriate buffered solutions as needed. It is important to follow these guidelines to ensure the stability and efficacy of the product.

Stability & Storage

To ensure the stability of this lyophilized preparation, it should be stored at 2-8 °C, but for long term storage, it is recommended to keep it at -20 °C, preferably desiccated. After reconstitution, the preparation can be stored for up to one week at 2-8 °C. To maintain its maximal stability, it is best to divide the reconstituted preparation into working aliquots and store them at temperatures between -20 °C and -70 °C. Avoiding repeated freeze/thaw cycles is important in maintaining the efficacy of this preparation.

Target

Accession

O35188

Gene IDs

20312